Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Natural killer (NK) cells attack tumor and infected cells, but the receptors and ligands that stimulate them are poorly understood. Here we report the expression cloning of two murine ligands for the lectin-like receptor NKG2D. The two ligands, H-60 and Rae1 beta, are distant relatives of major histocompatibility complex class I molecules. NKG2D ligands are not expressed by most normal cells but are up-regulated on numerous tumor cells. We show that mouse NKG2D is expressed by NK cells, activated CD8+ T cells and activated macrophages. Expression of either NKG2D ligand by target cells triggers NK cell cytotoxicity and interferon-gamma secretion by NK cells, as well as nitric oxide release and tumor necrosis factor alpha transcription by macrophages. Thus, through their interaction with NKG2D, H-60 and Rae1 beta are newly identified potent stimulators of innate immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies from our laboratory demonstrated that transplanted tumor cells expressing NKG2D ligands are rejected by NK cells and, in some cases, T cells (Diefenbach et al., 2000, 2001, 2003)”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Diefenbach et al., 2000
Citations
Cites
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,146 · cited 1×
“The extrachromosomal DNA was extracted from the sorted cells as describe”
MethodPhenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“The recombinant protein was purified from inclusion bodies and refolded in vitro as describe”
MethodActivation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999 · cited 1×
“The MHC-encoded proteins MICA and the closely related MICB are distantly related to MHC class I protein”
BackgroundBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902 · cited 2×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodIn search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialProduction of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialAn Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039 · cited 1×
“Recent evidence indicates that human NKG2D forms a homodimer that associates with the signaling subunit DAP10 on the surface of NK cells and CD8 + T cell”
BackgroundBroad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017 · cited 1×
“MICA and MICB are normally expressed on a subset of intestinal epithelial cells, but their expression is up-regulated by cellular stres”
Background
Research works printed but not linked: 2
- Cosman, D. et al. The human cytomegalovirus (HCMV) glycoprotein, UL16, binds to the MHC class I-related protein, MICB/PERB11, and to two novel, MHC class I-related molecules, ULBP1 and ULBP2. FASEB J. 14, A1018 (2000).
- Chalupny, J. et al. Soluble forms of the novel MHC class I–related molecules, ULBP1 and ULBP2, bind to, and functionally activate NK cells. FASEB J. 14, A1018 (2000).
Cited by
Items 501–600 of 875
Masuda, H., Saeki, Y., Nomura, M., Shida, K., Matsumoto, M., Ui, M., Lanier, L. L., & Seya, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6165 · Cited by 25
Zloza, A., Lyons, G. E., Chlewicki, L. K., Kohlhapp, F. J., O’Sullivan, J. A., Lacek, A. T., Moore, T. V., Jagoda, M. C., Kumar, V., & Guevara-Patino, J. A. (2011) · Autoimmunity · doi:10.3109/08916934.2011.593599 · Cited by 24
Cho, H.-M., Rosenblatt, J. D., Tolba, K. A., Shin, S. J., Shin, D. S., Calfa, C., Zhang, Y., & Shin, S.-U. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1047 · Cited by 27
“Specifically, NKG2D is expressed on the surface of most NK cells, activated CD8þ ab T cells, antigenspecific CD8þ memory T cells, a subset of gd T cells and on activated macrophages (10, 17).”
BackgroundRaju, S., Kretzmer, L. Z., Koues, O. I., Payton, J. E., Oltz, E. M., Cashen, A. F., Polić, B., Schreiber, R. D., Shaw, A. S., & Markiewicz, M. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501982 · Cited by 24
“Tumors of various origin express NKG2D ligands, which facilitates NK-mediated lysis of the tumor cells in vitro and allows for rejection of transplantable tumors in vivo (1, 12, 14).”
BackgroundHu, J., Bernatchez, C., Zhang, L., Xia, X., Kleinerman, E. S., Hung, M., Hwu, P., & Li, S. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0234 · Cited by 24
“The interaction between natural killer group 2D (NKG2D) and its ligands is a key mechanism for immune surveillance (3, 4).”
Interactions Between NK Cells and B Lymphocytes
Yuan, D. (2004) · Advances in immunology · doi:10.1016/s0065-2776(04)84001-x · Cited by 24
Yokoyama, W. M., & Riley, J. K. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60573-1 · Cited by 30
“Instead, NKG2D is expressed as a disulphide-linked homodimer on both peripheral and uNK cells as well as differing T cell subsets in humans and mice (Bauer et al., 1999; Cerwenka et al., 2000; Diefenbach et al., 2000; Groh et al., 2003; Kopcow et al., 2005; Xie et al., 2005; Hanna et al., 2006; Vacca et al., 2006).”
BackgroundLi, D., Ronson, B. B., Guo, M., Liu, S., Bishop, J. S., Echo, D. A. V., & O'Malley, B. W. (2002) · PubMed · Cited by 24
Self-citationA DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor
Zhou, H., Luo, Y., Kaplan, C., Krüger, J. A., Lee, S., Xiang, R., & Reisfeld, R. A. (2005) · Blood · doi:10.1182/blood-2005-10-4231 · Cited by 27
Wilhelm, B. T., Landry, J., Takei, F., & Mager, D. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4219 · Cited by 26
“Indeed, the NKG2D gene, which is on the other side of CD94, has a significantly different expression pattern (51, 52).”
BackgroundActivation of Immature Hepatic NK Cells As Immunotherapy for Liver Metastatic Disease
Bahjat, K. S., Prell, R. A., Allen, H. E., Liu, W., Lemmens, E. E., Leong, M. L. L., Portnoy, D. A., Dubensky, T. W., Brockstedt, D. G., & Giedlin, M. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7376 · Cited by 24
“NKG2D ligands are attractive candidates because of their role in normal tumor immune surveillance and tumor cell killing in vivo (36, 37).”
BackgroundTargeting NKG2D in tumor surveillance
Hayakawa, Y. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.681378 · Cited by 26
“Expression of the NKG2D ligands is not a ubiquitous feature of tumor cell lines, because the lymphoma cell lines RMA and RMA-S, and the C57BL/6 melanoma cell line B16 are known to be negative for NKG2D ligands [15,16,51,65].”
BackgroundMurine Cytomegalovirus and Other Herpesviruses
RSHELLAM, G., Redwood, A., MSMITH, L., & Gorman, S. (2007) · Elsevier eBooks · doi:10.1016/b978-012369454-6/50029-7 · Cited by 24
NK cells do not mediate renal injury in murine adriamycin nephropathy
Zheng, G., Zheng, L., Wang, Y., Wu, H., Kairaitis, L., Zhang, C., Tay, Y., Wang, Y., Alexander, S. I., & Harris, D. C. H. (2006) · Kidney International · doi:10.1038/sj.ki.5000244 · Cited by 24
Kondo, M., Maruoka, T., Otsuka, N., Kasamatsu, J., Fugo, K., Hanzawa, N., & Kasahara, M. (2010) · Immunogenetics · doi:10.1007/s00251-010-0438-z · Cited by 26
Abdool, K., Cretney, E., Brooks, A. D., Kelly, J. M., Swann, J. B., Shanker, A., Bere, E. W., Yokoyama, W. M., Ortaldo, J. R., Smyth, M. J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2575 · Cited by 23
“In the mouse, these ligands include H60 and the Rae1 family ( , , , , ) (13, 14) and the more recently identified MULT1 (15).”
BackgroundMa, W., Yu, H. C., Wang, Q., Jin, H., Solheim, J. C., & Labhasetwar, V. D. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000025451.41948.94 · Cited by 24
(2002) · doi:10.1002/1521-4141(200206)32:6<1726::aid-immu1726>3.0.co;2-r
DNA Damage and Tumor Surveillance: One Trigger for Two Pathways
Höglund, P. (2006) · Science s STKE · doi:10.1126/stke.3172006pe2 · Cited by 27
al-Ramadi, B. K., Mustafa, N., Haidar, M. A., & Fernández-Cabezudo, M. J. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00005-1 · Cited by 22
“Given the fact that IL-2 is a potent inducer of NK cell activity, including increased cytotoxicity and IFN- production (Biron et al., 1990; Diefenbach et al., 2000; Karupiah et al., 1990b), it is reasonable to postulate that the most likely cellular target of GIDIL2 is NK cells.”
BackgroundPlougastel-Douglas, B., & Yokoyama, W. M. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-27743-9_4 · Cited by 22
“recognized by the relevant NK cells (Bauer et al. 1999; Diefenbach et al. 2000).”
Innate immune cells for immunotherapy of autoimmune and cancer disorders
Schäfer, C., Ascui, G., Ribeiro, C. H., López, M. N., Prados‐Rosales, R., González, P. A., Bueno, S. M., Riedel, C. A., Baena, A., Kalergis, A. M., et al. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1365145 · Cited by 23
“Thus, the presence of NKG2D ligands (NKG2DL) potentially serves as ‘danger signals’ to alert the immune system to the existence of abnormal cells, contributing to their clearance [123].”
BackgroundPhysiological roles of murine DAP10 adapter protein in tumor immunity and autoimmunity
Hyka‐Nouspikel, N., & Phillips, J. H. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00456.x · Cited by 23
“The constitutive expression of NKG2D–DAP10 receptor complex and its ligands in lymphoid tissues, such as spleen and thymus, suggests a role for DAP10 in pathways involved in development of immune cells and in immune responses, under physiological conditions (2, 11, 20).”
BackgroundYokoyama, W. M. (2002) · Nature · doi:10.1038/419679a · Cited by 22
Immunotherapy for malignant glioma: current approaches and future directions
Sikorski, C. W., & Lesniak, M. S. (2005) · Neurological Research · doi:10.1179/016164105x49481 · Cited by 21
Poggi, A. D., & Zocchi, M. R. (2006) · Journal of Immunology Research · doi:10.1080/17402520600578194 · Cited by 21
Immunosurveillance by γδ T Cells: Focus on the Murine System
Girardi, M., & Hayday, A. (2005) · KARGER eBooks · doi:10.1159/000086658 · Cited by 22
Practical considerations for chimeric antigen receptor design and delivery
Oldham, R. A. A., & Medin, J. A. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1339687 · Cited by 22
Patil, S. B., Al-Jehani, R. M., Etayash, H., Turbé, V., Jiang, K., Bailey, J., Al‐Akkad, W., Soudy, R., Kaur, K., McKendry, R. A., et al. (2018) · Communications Biology · doi:10.1038/s42003-018-0179-3 · Cited by 20
Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response
Baugh, R. T., Khalique, H., & Seymour, L. W. (2020) · Cancers · doi:10.3390/cancers12123827 · Cited by 29
Walsh, K. B., Lodoen, M. B., Edwards, R. A., Lanier, L. L., & Lane, T. E. (2007) · Journal of Virology · doi:10.1128/jvi.02032-07 · Cited by 21
“Enhanced IFN- secretion by NK cells within the brains of MHV-CXCL10-infected mice might result from the increased local expression of ligands capable of binding to NK cell-activating receptors such as NKG2D (8).”
BackgroundThe Role of Platelets in Tumor Growth, Metastasis, and Immune Evasion
Li, Z., Riesenberg, B., Metelli, A., Li, A., & Wu, B. X. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00030-8 · Cited by 22
Rubio, M., Zhao, G., Buchli, J., Chittenden, M., & Sykes, M. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.03.004 · Cited by 20
In vivo immunogenetics: from MIC to RAET1 loci
Radosavljevic, M., & Bahram, S. (2003) · Immunogenetics · doi:10.1007/s00251-003-0546-0 · Cited by 24
“transcript-1 (RAET1 or RAE1) genes were somehow overlooked, at least by immunologists, until two groups identified their products as ligands for NKG2D, an activatory C-type lectin-like molecule, expressed on the majority of human T (gd as well as CD8+ ab) and NK cells, as well as mouse macrophages (Cerwenka et al. 200…”
BackgroundLoewendorf, A. I., Steinbrueck, L., Peter, C., Busche, A., Benedict, C. A., & Kay-Jackson, P. C. (2011) · Journal of Virology · doi:10.1128/jvi.02178-10 · Cited by 20
“The lack of H60 in B6 mice (13, 26, 30) allows for the study of possible effects of m155 on adaptive immune responses in the absence of its NK cell modulatory capacity.”
BackgroundDeuss, F. A., Watson, G. M., Goodall, K. J., Leece, I., Chatterjee, S., Fu, Z., Thaysen‐Andersen, M., Andrews, D. M., Rossjohn, J., & Berry, R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009261 · Cited by 19
Filtjens, J., Taveirne, S., Acker, A. V., Ammel, E. V., Vanhees, M., Kerre, T. C. C., Taghon, T., Vandekerckhove, B., Plum, J. R., & Leclercq, G. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0812378 · Cited by 19
“and RMA-Rae-1 target cells, as these cell lines express activating stress ligands for the NKG2D receptor on NK cells [40].”
Backgroundγδ T Cells as a Potential Tool in Colon Cancer Immunotherapy
Ramutton, T., Buccheri, S., Dieli, F., Todaro, M., Stassi, G., & Meraviglia, S. (2014) · Immunotherapy · doi:10.2217/imt.14.59 · Cited by 20
Thomas, D., Kranz, D. M., & Roy, E. J. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0467-8 · Cited by 20
“EL4-H60 cells were obtained from David Raulet and Andreas Diefenbach (University of California, Berkeley), and were generated from EL4 cells by retroviral transduction [6].”
NKG2D and CD94 bind to multimeric α2,3-linked N-acetylneuraminic acid
Imaizumi, Y., Higai, K., Suzuki, C., Azuma, Y., & Matsumoto, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.081 · Cited by 19
“MHC class I related chain family proteins (MIC) A and B [8] and the UL 16-binding proteins (ULBP) 1–4 [9] in humans; as well as H60 [10], the retinoic acid early inducible (RAE-1) [11] and murine ULBP-like transcript 1 (MULT-1) [12] in mice.”
BackgroundExtrinsic and intrinsic drivers of natural killer cell clonality
Rückert, T., & Romagnani, C. (2024) · Immunological Reviews · doi:10.1111/imr.13324 · Cited by 22
Comparative genomics of the NKG 2D ligand gene family
Kasahara, M., & Sutoh, Y. (2015) · Immunological Reviews · doi:10.1111/imr.12320 · Cited by 18
“They were later shown to function as ligands for the NKG2D receptor (50, 51).”
BackgroundLigand dimensions are important in controlling NK‐cell responses
Brzostek, J., Chai, J., Gebhardt, F. E., Busch, D. H., Zhao, R., van der Merwe, P. A., & Gould, K. G. (2010) · European Journal of Immunology · doi:10.1002/eji.201040335 · Cited by 18
Bone Marrow Allograft Rejection Mediated by a Novel Murine NK Receptor, NKG2I
Koike, J., Wakao, H., Ishizuka, Y., Sato, T., Hamaoki, M., Seino, K., Koseki, H., Nakayama, T., & Taniguchi, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030851 · Cited by 18
“This suggests that NKG2I forms homo- or heterodimer-like other NKG2 family members (21, 23, 24).”
BackgroundGodbersen, C., Coupet, T. A., Grada, Z., Zhang, S. C., & Sentman, C. L. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901401 · Cited by 20
DNA damage response and development of targeted cancer treatments
Gasser, S. (2007) · Annals of Medicine · doi:10.1080/07853890701436773 · Cited by 18
“The expression of different NKG2D ligands on cells in healthy adults is normally low or not detectable, except on bone marrow cells and mouse thymocytes (14,15).”
BackgroundPromising immunotherapy: Highlighting cytokine‐induced killer cells
Shirjang, S., Alizadeh, N., Mansoori, B., Mahmoodpoor, A., Kafil, H. S., Hojjat‐Farsangi, M., & Yousefi, M. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28250 · Cited by 18
Pedersen, L. Ø., Vetter, C. S., Mingari, M. C., Andersen, M. H., Straten, P. T., Bröcker, E., & Becker, J. C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01698.x · Cited by 18
Franco, A. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2005.01596.x · Cited by 20
Zwirner, N. W., Fuertes, M. B., Girart, M. V., Domaica, C. I., & Rossi, L. E. (2006) · Cited by 20
Milling, L. E., Garafola, D., Agarwal, Y., Wu, S., Thomas, A., Donahue, N. D., Adams, J., Thai, N., Suh, H., & Irvine, D. J. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0247 · Cited by 18
“The near ubiquity of these NK-activating ligands across breast tumors (38) in parallel with apparent dysfunction of NK cells, motivates the development of therapies that recruit NK cells to sites of metastasis and promote NK-cell activation as a treatment paradigm to clear metastases.”
Expression of NKG2D and Its Ligand in Mouse Heart Allografts May Have a Role in Acute Rejection
Feng, L., Ke, N., Ye, Z., Guo, Y., Li, S., Li, Q., & Li, Y. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.08.060 · Cited by 17
Zhang, H., Hardamon, C. R., Sagoe, B., Ngolab, J., & Bui, J. D. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.10.015 · Cited by 19
“It is known to be expressed by hematopoietic cells and tumor cell lines from various strains, including BALB/C and 129/Sv (Bui et al., 2006a; Cerwenka et al., 2000; Diefenbach et al., 2000; Malarkannan et al., 1998), but is a pseudogene in C57BL/6 mice.”
BackgroundMHC class I chain-related molecules induced on monocytes by IFN-γ promote NK cell activation
Wang, H., Ruan, Z., Wang, Y., Han, J., Fu, X., Zhao, T., Yang, D., Xu, W., Yang, Z., Wang, L., et al. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.007 · Cited by 16
Kawakami, T., Ito, K., Matsuda, Y., Noda, M., Sakurada, A., Hoshikawa, Y., Okada, Y., & Ogasawara, K. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14257 · Cited by 18
“Consistent with previous reports (39,40), in vitro analysis revealed that the cytotoxicity of NK cells was markedly affected by the expression of NKG2D ligands in target cells (Figure 6F).”
ResultModular Activating Receptors in Innate and Adaptive Immunity
Berry, R., & Call, M. E. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b01291 · Cited by 17
Su, X., Zhang, L., Jin, L., Ye, J., Guan, Z., & Chen, R. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9434-1 · Cited by 17
Wojtasiak, M. (2004) · International Immunology · doi:10.1093/intimm/dxh136 · Cited by 17
Wang, X., Li, A., Jing, H., Zhang, X., Dong, X., Song, Z., Wu, N., & Zheng, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1653472 · Cited by 18
Implications of a ‘Third Signal’ in NK Cells
Khalil, M., Wang, D., Hashemi, E., Terhune, S. S., & Malarkannan, S. (2021) · Cells · doi:10.3390/cells10081955 · Cited by 19
“Murine NKG2D ligands belong to n n-classical MHC Class-I and fall into three su -families, Rae1 [32], H60 [33], a d Mult1 [34].”
BackgroundInfluentialSavid-Frontera, C., Viano, M. E., Baez, N. S., Lidon, N. L., Fontaine, Q., Young, H. A., Vimeux, L., Donnadieu, E., & Rodriguez‐Galán, M. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.971001 · Cited by 16
Zimmerman, Z. F., & Levy, R. B. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01428.x · Cited by 16
“The importance of H60+CD8 T cells in host-versus-graft (HVG) resistance responses contrasts findings that such T cells are not important in allogeneic transplant responses mediating GVHD (49).”
BackgroundInfluentialLee, Y., Heo, W., Son, C., Kang, C., Park, Y.-S., & Bae, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10583 · Cited by 18
Characteristics of Peripheral Immune Function in Reproductive Females with Uterine Leiomyoma
Liu, Z.-Q., Lu, M.-Y., Sun, R., Yin, Z., Liu, B., & Wu, Y. (2019) · Journal of Oncology · doi:10.1155/2019/5935640 · Cited by 19
Plaza-Rojas, L., & Guevara-Patino, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624131 · Cited by 28
Uddin, M. B., Roy, K. R., Hill, R. A., Roy, S. C., Gu, X., Li, L., Zhang, Q.-J., You, Z., & Liu, Y. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113210 · Cited by 19
NKG2D‐ligands: Putting everything under the same umbrella can be misleading
Campos‐Silva, C., Kramer, M. K., & Valés‐Gómez, M. (2018) · HLA · doi:10.1111/tan.13246 · Cited by 18
“The degree of inflammation in CD patients proved to correlate inversely with the amounts of γδ T cells and CD56+ cells expressing NKG2D.”
BackgroundInfluentialHuang, M. M. S., Borszcz, P. D., Sidobre, S., Kronenberg, M., & Kane, K. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5304 · Cited by 15
AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
Maglakelidze, N., Gao, T., Feehan, R. P., & Hobbs, R. P. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.09.656 · Cited by 19
Saeki, S., Fukui, A., Mai, C., Takeyama, R., Yamaya, A., & Shibahara, H. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103765 · Cited by 16
Wickström, S. L., Öberg, L., Kärre, K., & Johansson, M. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300960 · Cited by 14
“We next tested killing of the prototype NK cell target YAC-1 cells, known to be highly sensitive to NK cell– mediated killing mainly via NKG2D (47).”
BackgroundHuang, R. Y. ‐., Kuhné, M. R., Deshpande, S. V., Rangan, V. S., Srinivasan, M., Wang, Y., & Chen, G. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02409-x · Cited by 16
NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells
Feng, P., Lam, B. K., Tseng, S.-H., Kung, Y.-J., Farmer, E. A., Cheng, M. A., & Hung, C. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02615-7 · Cited by 17
Ambrose, E. C., & Kornbluth, J. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0385-z · Cited by 15
NKG2D and CD94 bind to heparin and sulfate-containing polysaccharides
Higai, K., Imaizumi, Y., Suzuki, C., Azuma, Y., & Matsumoto, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.101 · Cited by 15
Augmentation of NK cell-mediated cytotoxicity to tumor cells by inhibitory NK cell receptor blockers
Tajima, K., Matsumoto, N., Ohmori, K., Wada, H., Ito, M., Suzuki, K., & Yamamoto, K. (2004) · International Immunology · doi:10.1093/intimm/dxh021 · Cited by 15
MHC and MHC‐related proteins as pleiotropic signal molecules
Ojcius, D. M., Delarbre, C., Kourilsky, P., & Gachelin, G. (2002) · The FASEB Journal · doi:10.1096/fj.01-0758com · Cited by 15
Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies
Khan-Farooqi, H., Prins, R. M., & Liau, L. M. (2005) · Neurological Research · doi:10.1179/016164105x49490 · Cited by 15
Tarazona, R., Gayoso, I., Alonso, C., Alonso, C., Peralbo, E., Casado, J. G., Sánchez-Correa, B., Morgado, S., & Solana, R. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_27 · Cited by 22
“Strong stimulatory signaling resulting from increased levels of stimulatory ligands can often overcome inhibitory signals provided by MHC class I molecules expressed on target cells (Bauer et al. 1999 ; Cerwenka et al. 2000 ; Diefenbach et al. 2000 ).”
BackgroundPoggi, A. D., Zancolli, M., Boero, S., Catellani, S., Musso, A., & Zocchi, M. R. (2010) · International Journal of Cancer · doi:10.1002/ijc.25682 · Cited by 14
Suzawa, K., Shien, K., PENG, H., Sakaguchi, M., Watanabe, M., Hashida, S., Maki, Y., Yamamoto, H., Tomida, S., Soh, J., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11321 · Cited by 14
Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts
Fabritius, C., Ritschl, P. V., Resch, T., Roth, M., Ebner, S., Günther, J., Mellitzer, V., Nguyen, A.-V., Pratschke, J., Sauter, M., et al. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14467 · Cited by 14
“On the other hand, the functional relevance of individual NK cell receptors in SOT has been studied exclusively for the activating cytotoxicity receptor NKG2D, which is also expressed by activated (human) or constitutively by (mouse) CD8 T cells (11,12), subsets of NKT cells, and IFNγproducing killer dendritic cells (…”
Nature killer cells in the central nervous system
Shi, F., & Ransohoff, R. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-370454-2.00028-4 · Cited by 14
“The endogenous ligand of NKG2D in the mouse was recently identified as retinoic acid early inducible gene-1 (RAE-1)-encoded proteins and minor histocompatibility antigen H60 (Cerwenka et al., 2000; Diefenbach et al., 2000; Malarkannan et al., 1998) .”
BackgroundInnate Tumor Immune Surveillance
Smyth, M. J., Swann, J. B., & Hayakawa, Y. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-34814-8_7 · Cited by 14
Redirecting NK cells mediated tumor cell lysis by a new recombinant bifunctional protein
Germain, C., Campigna, E., Salhi, I., Morisseau, S., Navarro‐Teulon, I., Mach, J. P., Pèlegrin, A., & Robert, B. (2008) · Protein Engineering Design and Selection · doi:10.1093/protein/gzn047 · Cited by 18
“…tumor cell types, such as human epithelial carcinomas, melanomas, gliomas and leukemias (Pende et al., 2002; Vetter et al., 2002; Friese et al., 2003; Salih et al., 2003) or mouse epithelial carcinomas and lymphomas (Cerwenka et al., 2000; Diefenbach et al., 2000; Carayannopoulos et al., 2002).”
BackgroundKotturi, H. S. R., Li, J., Branham-O’Connor, M., Stickel, S. L., Yu, X., Wagner, T. E., & Wei, Y. (2008) · Gene Therapy · doi:10.1038/gt.2008.77 · Cited by 16
Zhang, H., Li, N., Zhang, J., Jin, F., Shan, M., Qin, J., & Wang, Y. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1177678 · Cited by 14
“In mice, NKG2D is mainly to identify and combine retinoic acid early transcription factor 1 (Rae1), histocompatibility 60 antigen (H60a) and Ulbp1 binding protein1 (MULT1).(15) Wang et al”
BackgroundMorvan, M. G., Champsaur, M., Reizis, B., & Lanier, L. L. (2017) · ImmunoHorizons · doi:10.4049/immunohorizons.1700004 · Cited by 14
“Isolated NK cells were cultured overnight, and degranulation (CD107a expression) after coculture with YAC-1 target cells was measured by flow cytometry for CD11c-Rae1 NK cells (white bar) and their littermate control NK cells (gray bar), in three independent experiments each performed in triplicate (p = 0.59).”
MethodInfluentialInnate lymphoid cells and cancer at border surfaces with the environment
Mattiola, I., & Diefenbach, A. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.06.001 · Cited by 13
Self-citationThe origins of resident macrophages in mammary gland influence the tumorigenesis of breast cancer
Yang, Y., Hou, J., Liu, J., Bhushan, S., & Wu, G. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109047 · Cited by 16
Innate lymphoid cells in early tumor development
Warner, K., Ghaedi, M., Chung, D. C., Jacquelot, N., & Ohashi, P. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.948358 · Cited by 14
Modulation of antitumour immune responses by intratumoural Stat1 expression
Messina, N. L., Banks, K. M., Vidacs, E., Martin, B. P., Long, F., Christiansen, A. J., Smyth, M. J., Clarke, C. J. P., & Johnstone, R. W. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.41 · Cited by 14
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-lnduced Killer Cells
Mesiano, G., Zini, R., Montagner, G., Bianchi, N., Manfredini, R., Chillemi, A., Aglietta, M., Grignani, G., Lampronti, I., Fiorino, E., et al. (2017) · Molecular Medicine · doi:10.2119/molmed.2017.00084 · Cited by 13
NK Cell‐mediated Destruction of Influenza A Virus‐infected Peripheral but not Central Neurones
Backström, E., Ljunggren, H., & Kristensson, K. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.01912.x · Cited by 15
Commentary on CAM and NK Cells by Kazuyoshi Takeda and Ko Okumura
Cooper, E. L. (2004) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/neh011 · Cited by 14
Wang, W.-J., Qin, S., Zhang, J., Jiang, Y., Zhang, J.-N., & Zhao, L. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.22.9667 · Cited by 13
“NKG2D ligands consist of the Rae-1 family, H60 and Mult-1 in mice (Diefenbach et al., 2000; Carayannopoulos et al., 2002).”
BackgroundGiraudo, L., Cattaneo, G., Gammaitoni, L., Iaia, I., Donini, C., Massa, A., Centomo, M. L., Basiricò, M., Vigna, E., Pisacane, A. M., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02884-x · Cited by 12
“The intrinsic HLA-independent cytotoxic ability of CIK is mainly mediated by the NKG2D receptor, which binds stress-inducible molecules (MIC A/B, ULBPs) selectively expressed by cancer cells [24].”
BackgroundCédile, O., Popa, N., Pollet-Villard, F., Garmy, N., Ibrahim, E. C., & Boucraut, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013466 · Cited by 15
“RAE-1 is overexpressed in tumor cell lines [1,4,5] and its expression is induced after viral infection [6,7] and genotoxic stress [8].”
BackgroundNKG2D Enhances Double-Negative T Cell Regulation of B Cells
Hu, S.-H., Zhang, L.-H., Gao, J., Guo, J.-H., Xun, X., Xiang, X., Cheng, Q., Zhao, L., & Zhu, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.650788 · Cited by 14
“upregulated the protein expression of the NKG2D ligand upon LPS stimulation (Figures 5D, E and Supplementary Figures 1A–C), which is consistent with a previous study that B cells were significantly stained with the NKG2D tetramer after stimulation of splenocytes with ConA or LPS (33).”
ResultOsaki, T., Saito, H., Fukumoto, Y., Yamada, Y., Fukuda, K., Tatebe, S., Tsujitani, S., & Ikeguchi, M. (2008) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2008.00855.x · Cited by 12
Metadata
- Authors
- Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature Immunology
- Published
- 2000-08
- Volume
- 1
- Issue
- 2
- Pages
- 119-126
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1603913234
- Cited by
- 878
- References
- 41
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 17 · 2023: 12 · 2022: 28 · 2021: 17 · 2020: 23 · 2019: 18 · 2018: 29 · 2017: 31 · 2016: 17 · 2015: 23 · 2014: 24 · 2013: 28 · 2012: 38
- FWCI
- 18.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NKG2D, NKG2D ligands, natural killer cells, macrophages, cancer cells, innate immunity, NK cell cytotoxicity, interferon-gamma, nitric oxide, TNF-α, MHC class I-related molecules, CD8+ T cells, expression cloning
- MeSH terms
- Animals, Chlorocebus aethiops, Cloning, Molecular, Cricetinae, Humans, Killer Cells, Natural, Ligands, Lymphocyte Activation, Macrophage Activation, Membrane Proteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, Immunologic, Tumor Cells, Cultured, Minor Histocompatibility Antigens, CHO Cells, Macrophages, Peritoneal, COS Cells, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.